ArticleJACS Au2025
Single Photocatalytic Hydrosilylation of Alkenes for the Synthesis of Bis(silyl) and Silaboryl Alkanes.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bis-(silyl) and silaboryl alkanes are of interest as bioactive compounds and highly functionalized synthetic building blocks, but conventional hydrosilylation reactions lack generality and/or selectivity for synthesizing multielement-containing alkanes. Here, we present a versatile photoactivated hydrosilylation reaction of silicon- or boron-containing alkenes using silylborane as a silyl radical source to construct bis-(silyl) or silaboryl alkanes. This method employs a single phenothiazine-based photocatalyst and does not require conventional transition-metal or hydrogen-atom-transfer (HAT) catalysts or cocatalysts. Consequently, it has high generality, including alkenes bearing acid/base-sensitive groups, and provides high chemo-/regio-selectivity, overcoming the limitations of existing methods. This methodology also enables cyclizative functionalization of dienes and arylsilylation of boryl alkenes, and we show that the obtained multielement-containing alkanes are useful synthetic building blocks. Mechanistic studies uncovered a novel photoactivation mechanism, in which the phenothiazine catalyst directly facilitates Si-B bond cleavage in the triplet state, in contrast to conventional redox or HAT mechanisms, enabling radical hydrosilylation with a broad scope of alkenes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.